Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass

Circulation Research

Volumn 86, Issue 9, 2000, Pages 1004-1007

  Talmor, Daniel ^a   Applebaum, Azai ^a   Rudich, Assaf ^a   Shapira, Yoram ^a   Tirosh, Amir ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Ischemia reperfusion; Myocardium; Stress activated protein kinases

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVATION; FEMALE; HEART MUSCLE BIOPSY; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034640271     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.9.1004     Document Type: Article

References (26)

1. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9: 726-735.
2. Sugden PH, Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res. 1998;83:345-352.
3. Sugden PH, Clerk A Cellular mechanisms of cardiac hypertrophy. J Mol Med. 1998;76:31-40.
4. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res. 1996;79:162-173.
5. Omura T, Yoshiyama M, Shimada T, Shimizu N, Kim S, Iwao H, Takeuchi K, Yoshikawa J. Activation of mitogen-activated protein kinases in in-vivo ischemia/reperfused myocardium in rats. J Mol Cell Cardiol. 1999;31:1269-1279.
6. Laderoute KR, Webster KA. Hypoxia/reoxygenation stimulates Jun-kinase activity through redox signaling in cardiac myocytes. Circ Res. 1997;80:336-344.
7. Seko Y, Takahashi N, Tobe K, Kadowaki T, Yazaki Y. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38-MAPK, and SAPK in cultured rat cardiac myocytes. Biochem Biophys Res Commun. 1997;239:840-844.
8. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol. 1999;276:H1468-H1481.
9. Clerk A, Fuller SJ, Michael A, Sugden PH. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem. 1998;273:7228-7234.
10. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, Yazaki Y. Oxidative stress activates ERKs through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest. 1997; 100:1813-1821.
11. Cook SA, Sugden PH, Clerk A. Activation of c-Jun N-terminal kinases and p38-MAPKs in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol. 1999;31:1429-1434.
12. Tirosh A, Potashnik R, Bashan N, Rudich A. Oxidative-stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 (IRS-1) and phosphatidylinositol (PI) 3-kinase in 3T3-L1 adipocytes. J Biol Chem. 1999;274:10595-10602.
13. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808-811.
14. Chan EY, Stang SL, Bottorff DA, Stone JC. Hypothermic stress leads to activation of Ras-Erk signaling. J Clin Invest. 1999;103:1337-1344.
15. Jovanovic A, Alekseev AE, Lopez JR, Shen WK, Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg. 1997;63:153-161.
16. Egea J, Espinet C, Comelia JX. Calcium influx activates extracellular-regulated kinase/MAPK pathway through a calmodulin-sensitive mechanism in PC12 cells. J Biol Chem. 1999;274:75-85.
17. Lazou A, Sugden PH, Clerk A. Activation of MAPKs (p38-MAPKs, SAPKs/JNKs and ERKs) by the G protein-coupled receptor agonist phenylephrine in the perfused rat heart. Biochem J. 1998;332:459-465.
18. Lazou A, Bogoyevitch MA, Clerk A, Fuller SJ, Marshall CJ, Sugden PH. Regulation of mitogen-activated protein kinase cascade in adult rat heart preparations in vitro. Circ Res. 1994;75:932-941.
19. di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol. 1999;277:F195-F203.
20. 2-terminal kinase pathway in H9C2 cardiac muscle cells. J Mol Cell Cardiol. 1998;30:1789-1801.
21. Huot J, Houle F, Marceau F, Landry J. Oxidative stress-induced actin reorganization mediated by the p38-MAPK/heat-shock protein 27 pathway in vascular endothelial cells. Circ Res. 1997;80:383-392.
22. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL. Inhibition of p38-MAPK decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 1999;99:1685-1691.
23. Cain BS, Meldrum DR, Meng X, Dinarello CA, Shames BD, Banerjee A, Harken AH. p38-MAPK inhibition decreases TNF-α production and enhances postischemic human myocardial function. J Surg Res. 1999; 83:7-12.
24. Boldt J, Rothe G, Schindler E, Doll C, Gortach G, Hempelmann G. Can clonidine, enoximone and enalaprilat help to protect the myocardium against ischemia in cardiac surgery? Heart. 1996;76:207-213.
25. Gurevitch J, Pevni D, Frolkis I, Matsa M, Paz Y, Mohr R, Yakirevich V. Captopril in cardioplegia and reperfusion: protective effects on the ischemie heart. Ann Thorac Surg. 1997;63:627-633.
26. Tanonaka K, Kamiyama T, Takezono A, Sakai K, Takeo S. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart. J Mol Cell Cardiol. 1996;28: 1659-1670.